O. James

O. James is a seasoned financial leader with extensive experience in the biotechnology, healthcare, and investment sectors. Currently, O. James serves as a Member of the Board of Directors and Chair of the Audit Committee at Star Mountain Capital, a closed-end management investment company regulated by the SEC. O. James previously held the position of Chief Financial Officer at bluebird bio, a biotechnology company renowned for its FDA-approved gene therapies, and at Renalytix, where O. James oversaw the financial aspects of the company's IPO. Other notable roles include Partner at Renwick Capital, LLC, providing financial advisory services, and Managing Director at Brock Capital Group LLC, specializing in M&A and corporate finance. O. James holds an MBA in Operations and Finance from Columbia Business School and a BA in Alternative Energy and Environmental Science from Boston University.